Evaluation and Validation of a New Questionnaire to Identify and Quantify Abdominal Symptoms in Patients With Cystic Fibrosis Following FDA Guidelines: the CF Abd-Score (Primarily Named JenAbdomen-CF Score)
Evaluation and Validation of a New Questionnaire to Identify and Quantify Abdominal Symptoms in Patients With Cystic Fibrosis Following FDA Guidelines: the CF Abd-Score (Primarily Named JenAbdomen-CF Score)
Development, validation and evaluation of a new multimodal questionnaire to assess and quantify the abdominal involvement in patients with the inherited life shortening multi-organ disease Cystic fibrosis.
In the stepwhise development of the patient reported outcome measures (PROM) repeadedly, CF-patients, their families as well as professionals working in different fields of CF-care will be included.
Development of a multimodal questionnaire considering the FDA guidelines for development of a PROM, the CFAbd-Score
Development and validation of a CF-specific tool for daily assessment of abdominal symptoms (patient diary), the CFAbd-day2day
Development and validation of a CF-specific tool for assessment of abdominal symptoms in children < 12 years of age, the CFAbd-kid
Inclusion Criteria:
CF cohort:
Diagnosis of CF determined by
Healthy controls:
Exclusion Criteria:
CF cohort:
Healthy controls:
jochen.mainz@mhb-fontane.de+493381411803
f.duckstein@klinikum-brandenburg.de+493381411841
Brandenburg an der Havel, 14770, Germany
jochen.mainz@mhb-fontane.de+493381411803
f.duckstein@klinikum-brandenburg.de+493381411841
jochen.mainz@mhb-fontane.de+493381411803
f.duckstein@klinikum-brandenburg.de